Number of the records: 1
hepcidíny
SYS d064451 LBL 00000nz--a2200181n--4500 005 20250606221123.5 008 140101|||anznnbabn-----------|-a|a------ 040 $b slo $a BA006 $a BA006 $d BA006 065 $a D12.776.494.249 065 $a D12.776.543.695.054.425 066 $a 01 $c 03 150 $a hepcidíny $x AD $x AE $x AG $x AI $x AN $x BI $x BL $x CF $x CH $x CL $x CS $x DE $x DF $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 550 $7 sllk_us_auth*d000740 $Y Anemia $w b $a anémia 550 $7 sllk_us_auth*d006432 $Y Hemochromatosis $w b $a hemochromatóza 550 $7 sllk_us_auth*d000890 $Y Anti-Infective Agents $w P $a látky antiinfekčné 550 $7 sllk_us_auth*d000740 $Y Anemia $w p $a anémia 550 $7 sllk_us_auth*d006432 $Y Hemochromatosis $w p $a hemochromatóza 665 $a 2014 $2 eng 665 $a Antimicrobial Cationic Peptides (2013) $2 eng 680 9-
$i Forms of hepcidin, a cationic amphipathic peptide synthesized in the liver as a prepropeptide which is first processed into prohepcidin and then into the biologically active hepcidin forms, including in human the 20-, 22-, and 25-amino acid residue peptide forms. Hepcidin acts as a homeostatic regulators of iron metabolism and also possesses antimicrobial activity. $2 eng 750 -2
$a Hepcidins $2 eng 980 $x M
Number of the records: 1